Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02783664 · ClinicalTrials.gov registry record

Evaluating the Effects of Genetic Testing on Patients' Stress Levels

A clinical trial of Breast Cancer, sponsored by Medical College of Wisconsin.

Active
Registry status
164
Enrollment target
1
Study location

NCT02783664 is a study of Breast Cancer that is active but no longer recruiting, run by Medical College of Wisconsin. The registered enrollment target is 164 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02783664, a study of Breast Cancer, is active but no longer recruiting, sponsored by Medical College of Wisconsin.

ACTIVE NOT RECRUITING
Registry status
164 participants
Enrollment target
1
Study location

Study Summary

This prospective Medical College of Wisconsin Cancer Center study will evaluate stress levels in breast cancer patients undergoing genetic testing. It aims to establish baseline stress levels, evaluate pre- and post-test stress levels at multiple time points, focus on the changes in stress levels for the different resulting subgroups. This will help the clinical staff to provide better care for patients both medically and psychologically through potential interventions to decrease stress.

Conditions Studied

Interventions

  • OTHER Questionnaires to Evaluate Anxiety Related to Genetic Testing

Study Locations (1)

Wisconsin

  • Froedtert Hospital - Milwaukee

Trial Details

FieldValue
Enrollment Target 164 participants
Start Date 2016-07
Est. Completion 2027-07

Sponsor

Medical College of Wisconsin

447 total trials

What the Registry Record Tells You About NCT02783664

The ClinicalTrials.gov registry entry for NCT02783664 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 164 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (94% lower). The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Questionnaires to Evaluate Anxiety Related to Genetic Testing is the first listed.

NCT02783664 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT02783664 about?

NCT02783664 is a clinical study titled "Evaluating the Effects of Genetic Testing on Patients' Stress Levels". This prospective Medical College of Wisconsin Cancer Center study will evaluate stress levels in breast cancer patients undergoing genetic testing. It aims to establish baseline stress levels, evaluate pre- and post-test stress levels at multiple time points, focus on the changes in stress levels fo...

What is the current status of trial NCT02783664?

This trial is currently active not recruiting. The enrollment target is 164 participants. The study started on 2016-07. Estimated completion is 2027-07.

What conditions does trial NCT02783664 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT02783664?

The interventions under investigation include: Questionnaires to Evaluate Anxiety Related to Genetic Testing (OTHER).

Who is sponsoring clinical trial NCT02783664?

This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02783664 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.